Mediclinic Intnl plc - Disclosure Of Rights Attached To Equity Shares
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
("Mediclinic", the "Company", or the "Group")
Listing Rule 9.2.6E Confirmation
(Disclosure of rights attached to equity shares)
In accordance with paragraph 9.2.6E (disclosure of rights attached to equity shares) of the Listing Rules of the Financial Conduct Authority (the "
There have been no changes to the rights attached to the ordinary shares of the Company since the publication of the Prospectus.
The NSM can be accessed at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
Mediclinic is an international private healthcare services group, established in
The Group's core purpose is to enhance the quality of life.
Its vision is to be the partner of choice that people trust for all their healthcare needs.
Mediclinic is focused on providing specialist-orientated, multi-disciplinary services across the continuum of care in such a way that the Group will be regarded as the most respected and trusted provider of healthcare services by patients, medical practitioners, funders and regulators of healthcare in each of its markets.
Mediclinic comprises 77 hospitals, five sub-acute hospitals, 15 day case clinics and 22 outpatient clinics.
The Company's primary listing is on the
Mediclinic also holds a 29.9% interest in Spire Healthcare Group plc, a leading private healthcare group based in the
For further information, please contact:
Link Company Matters Limited
+44 (0)20 7954 9569
+44 (0)20 3786 8181
+44 (0)20 3727 1000
+27 (0)21 487 9000
Registered address: 6th Floor,
JSE sponsor (
NSX sponsor (
This information is provided by RNS, the news service of the